{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T23:26:13Z","timestamp":1761175573772,"version":"build-2065373602"},"reference-count":23,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Biomedical Research Institute grant, Kyungpook National University Hospital"},{"name":"Ministry of Health & Welfare, Republic of Korea","award":["HI15C0001","RS-2022-KH130593"],"award-info":[{"award-number":["HI15C0001","RS-2022-KH130593"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>The platelet-to-lymphocyte ratio (PLR) has been used as a marker of inflammation, endothelial damage, and a predictor of mortality. Expanded hemodialysis (HDx) using medium cut-off dialyzer (MCO) can effectively clear medium-sized uremic toxins. This study evaluated the effect of the Theranova dialyzer, a type of MCO dialyzer, on PLR and uremia-related inflammatory markers. A total of 44 patients with maintenance hemodialysis (HD) using high-flux dialyzer were randomly allocated to the Theranova or high-flux group. PLR and inflammatory markers including fibroblast growth factor 23, tumor necrosis factor-\u03b1 (TNF-\u03b1), and interleukin 6 were evaluated every 4 weeks. The changes in PLR and the reduction ratio of inflammatory markers were compared between two groups during the 12-week study period. The baseline characteristics and PLR were not different between groups. After 12 weeks, the levels of PLR, and TNF-\u03b1 were significantly lower in the Theranova group compared to the high-flux group (all p &lt; 0.05). The generalized estimating equation model also revealed a significant decrease in PLR over time in the Theranova group than in the high-flux group (p = 0.04). The fold change in 12-week PLR to baseline PLR was lower in the Theranova group than in the high-flux group (p = 0.03). In the multivariable linear regression analysis, the Theranova dialyzer showed a negative correlation with the PLR fold change (\u03b2 = \u22120.32, p = 0.04). Our results showed that HDx using the Theranova dialyzer improves PLR over time compared to the high-flux HD. The superior removal of the inflammatory uremic toxins by the Theranova dialyzer may have reduced inflammation and inflammation-related complications in HD patients.<\/jats:p>","DOI":"10.3390\/toxins17110521","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T08:41:08Z","timestamp":1761122468000},"page":"521","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of Expanded Hemodialysis with the Theranova Dialyzer on the Platelet-to-Lymphocyte Ratio and Inflammatory Markers"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7318-5753","authenticated-orcid":false,"given":"You Hyun","family":"Jeon","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee-Yeon","family":"Jung","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9774-3665","authenticated-orcid":false,"given":"Ji-Young","family":"Choi","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0953-3343","authenticated-orcid":false,"given":"Sun-Hee","family":"Park","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4648-0324","authenticated-orcid":false,"given":"Chan-Duck","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1344-3455","authenticated-orcid":false,"given":"Yong-Lim","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5517-9886","authenticated-orcid":false,"given":"Jeong-Hoon","family":"Lim","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7031-5214","authenticated-orcid":false,"given":"Jang-Hee","family":"Cho","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1046\/j.1523-1755.1999.00422.x","article-title":"Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure","volume":"55","author":"Stenvinkel","year":"1999","journal-title":"Kidney Int."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"iii35","DOI":"10.1093\/ndt\/gfy175","article-title":"Chronic inflammation in end-stage renal disease and dialysis","volume":"33","author":"Cobo","year":"2018","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1046\/j.1523-1755.1999.00273.x","article-title":"Inflammation enhances cardiovascular risk and mortality in hemodialysis patients","volume":"55","author":"Zimmermann","year":"1999","journal-title":"Kidney Int."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"199","DOI":"10.5414\/CN108584","article-title":"Neutrophil-to-lymphocyte ratio and platelet-tolymphocyte ratio in evaluation of inflammation in end-stage renal disease","volume":"85","author":"Ahbap","year":"2016","journal-title":"Clin. Nephrol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Mure\u0219an, A.V., Russu, E., Arb\u0103na\u0219i, E.M., Kaller, R., Hosu, I., Arb\u0103na\u0219i, E.M., and Void\u0103zan, S.T. (2022). The Predictive Value of NLR, MLR, and PLR in the Outcome of End-Stage Kidney Disease Patients. Biomedicines, 10.","DOI":"10.3390\/biomedicines10061272"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.2215\/CJN.02660221","article-title":"Classification of Uremic Toxins and Their Role in Kidney Failure","volume":"16","author":"Rosner","year":"2021","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/S0140-6736(14)60384-6","article-title":"Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure","volume":"383","author":"Ortiz","year":"2014","journal-title":"Lancet"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2215\/CJN.10110917","article-title":"Exploring the Clinical Relevance of Providing Increased Removal of Large Middle Molecules","volume":"13","author":"Wolley","year":"2018","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.2215\/CJN.10441015","article-title":"Biomarkers of Cardiovascular Disease and Mortality Risk in Patients with Advanced CKD","volume":"11","author":"Sun","year":"2016","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.kint.2016.10.021","article-title":"Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease","volume":"91","author":"Isakova","year":"2017","journal-title":"Kidney Int."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"328","DOI":"10.5301\/ijao.5000603","article-title":"Medium cut-off membranes\u2014Closer to the natural kidney removal function","volume":"40","author":"Zweigart","year":"2017","journal-title":"Int. J. Artif. Organs"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/1744-9987.12380","article-title":"The Predictive Value of Platelet\/Lymphocyte Ratio in Hemodialysis Patients With Erythropoietin Resistance","volume":"20","author":"Taymez","year":"2016","journal-title":"Ther. Apher. Dial."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Zickler, D., Schindler, R., Willy, K., Martus, P., Pawlak, M., Storr, M., Hulko, M., Boehler, T., Glomb, M.A., and Liehr, K. (2017). Medium Cut-Off (MCO) Membranes Reduce Inflammation in Chronic Dialysis Patients-A Randomized Controlled Clinical Trial. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0169024"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1007\/s11255-020-02562-3","article-title":"Effects of medium cut-off dialysis membranes on inflammation and oxidative stress in patients on maintenance hemodialysis","volume":"52","author":"Yeter","year":"2020","journal-title":"Int. Urol. Nephrol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Lim, J.H., Jeon, Y., Yook, J.M., Choi, S.Y., Jung, H.Y., Choi, J.Y., Park, S.H., Kim, C.D., Kim, Y.L., and Cho, J.H. (2020). Medium cut-off dialyzer improves erythropoiesis stimulating agent resistance in a hepcidin-independent manner in maintenance hemodialysis patients: Results from a randomized controlled trial. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-73124-x"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1681\/ASN.0000000655","article-title":"Expanded Hemodialysis with Theranova Dialyzer and Residual Kidney Function in Patients Starting Long-Term Hemodialysis: A Randomized Controlled Trial","volume":"36","author":"Lim","year":"2025","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/ckj\/sfad033","article-title":"Expanded hemodialysis: What\u2019s up, Doc?","volume":"16","author":"Coll","year":"2023","journal-title":"Clin. Kidney J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1093\/ckj\/sfac167","article-title":"Comparison of four medium cut-off dialyzers","volume":"15","author":"Maduell","year":"2022","journal-title":"Clin. Kidney J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/ckj\/sfy004","article-title":"Evaluation of the efficacy of a medium cut-off dialyser and comparison with other high-flux dialysers in conventional haemodialysis and online haemodiafiltration","volume":"11","author":"Vega","year":"2018","journal-title":"Clin. Kidney J."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Kim, T.H., Kim, S.H., Kim, T.Y., Park, H.Y., Jung, K.S., Lee, M.H., Jhee, J.H., Lee, J.E., Choi, H.Y., and Park, H.C. (2019). Removal of large middle molecules via haemodialysis with medium cut-off membranes at lower blood flow rates: An observational prospective study. BMC Nephrol., 21.","DOI":"10.1186\/s12882-019-1669-3"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000513328","article-title":"Expanded Hemodialysis and Its Effects on Hospitalizations and Medication Usage: A Cohort Study","volume":"145","author":"Sanabria","year":"2021","journal-title":"Nephron"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Lim, J.H., Park, Y., Yook, J.M., Choi, S.Y., Jung, H.Y., Choi, J.Y., Park, S.H., Kim, C.D., Kim, Y.L., and Cho, J.H. (2020). Randomized controlled trial of medium cut-off versus high-flux dialyzers on quality of life outcomes in maintenance hemodialysis patients. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-64622-z"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"ii5","DOI":"10.1093\/ndt\/gfm022","article-title":"EBPG guideline on dialysis strategies","volume":"22","author":"Tattersall","year":"2007","journal-title":"Nephrol. Dial. Transplant."}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/17\/11\/521\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T08:45:43Z","timestamp":1761122743000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/17\/11\/521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":23,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["toxins17110521"],"URL":"https:\/\/doi.org\/10.3390\/toxins17110521","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,22]]}}}